Market Cap 1.02B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 2,369,100
Avg Vol 3,776,030
Day's Range N/A - N/A
Shares Out 303.16M
Stochastic %K 9%
Beta 0.84
Analysts Strong Sell
Price Target $9.17

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
BullishReactions
BullishReactions Mar. 28 at 8:03 PM
0 · Reply
Rastafari
Rastafari Mar. 28 at 6:00 PM
$ABCL Let’s have some fun. with ABCL635 read out expected in Q3 and the stock trading in the three dollar range today, as we enter Q4, what are your projections for the stock price with a positive read out? Let me start, $5.50. Let’s hear from everyone who has a stake in the company.
1 · Reply
DragonAlgo
DragonAlgo Mar. 28 at 12:12 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-07-17 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.62 Stop: $0.45 TP1: $0.81 TP2: $1.06 TP3: $1.50 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
Odoji
Odoji Mar. 27 at 1:55 PM
$ABCL 💉
0 · Reply
tkstockpicker
tkstockpicker Mar. 27 at 1:44 PM
$ABCL 🍿
0 · Reply
8008track
8008track Mar. 26 at 8:47 PM
$ABCL I bought more today, fwiw
0 · Reply
DragonAlgo
DragonAlgo Mar. 26 at 5:35 PM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-07-17 | Strike: $5.00 | Type: CALL Option Plan (premium): Entry: $0.43 Stop: $0.31 TP1: $0.55 TP2: $0.72 TP3: $1.02 🔗 https://dragonalgo.com
0 · Reply
8008track
8008track Mar. 26 at 2:01 PM
$ABCL I’m not a technical trader so take this with a grain of salt. I generally buy and hold good companies with asymmetry long term. That being said, this does look like it’s made a long term higher low and we may break out to the upside and eventually get above $6.5 to make a higher high. The recent Feb 2026 low is higher than May 2025 low. Not financial advice. I’ll be holding through abcl635 readout regardless of price action and then reassess from there. And I do plan on buying a few more before then.
2 · Reply
tradersunion353
tradersunion353 Mar. 25 at 7:52 PM
$ABCL ABCL wasted another day for long term investors 🤮🤮🤮🤮🤮
2 · Reply
ispy
ispy Mar. 25 at 5:07 PM
$ABCL has same issue as Kermit... it's not easy being green.
0 · Reply
Latest News on ABCL
AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 weeks ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 4 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 5 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 6 months ago

AbCellera Biologics: Entering Growth Phase After A Pause


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 7 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 11 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 11 months ago

AbCellera Reports Q1 2025 Business Results


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition


AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty


BullishReactions
BullishReactions Mar. 28 at 8:03 PM
0 · Reply
Rastafari
Rastafari Mar. 28 at 6:00 PM
$ABCL Let’s have some fun. with ABCL635 read out expected in Q3 and the stock trading in the three dollar range today, as we enter Q4, what are your projections for the stock price with a positive read out? Let me start, $5.50. Let’s hear from everyone who has a stake in the company.
1 · Reply
DragonAlgo
DragonAlgo Mar. 28 at 12:12 AM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-07-17 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.62 Stop: $0.45 TP1: $0.81 TP2: $1.06 TP3: $1.50 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
Odoji
Odoji Mar. 27 at 1:55 PM
$ABCL 💉
0 · Reply
tkstockpicker
tkstockpicker Mar. 27 at 1:44 PM
$ABCL 🍿
0 · Reply
8008track
8008track Mar. 26 at 8:47 PM
$ABCL I bought more today, fwiw
0 · Reply
DragonAlgo
DragonAlgo Mar. 26 at 5:35 PM
🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-07-17 | Strike: $5.00 | Type: CALL Option Plan (premium): Entry: $0.43 Stop: $0.31 TP1: $0.55 TP2: $0.72 TP3: $1.02 🔗 https://dragonalgo.com
0 · Reply
8008track
8008track Mar. 26 at 2:01 PM
$ABCL I’m not a technical trader so take this with a grain of salt. I generally buy and hold good companies with asymmetry long term. That being said, this does look like it’s made a long term higher low and we may break out to the upside and eventually get above $6.5 to make a higher high. The recent Feb 2026 low is higher than May 2025 low. Not financial advice. I’ll be holding through abcl635 readout regardless of price action and then reassess from there. And I do plan on buying a few more before then.
2 · Reply
tradersunion353
tradersunion353 Mar. 25 at 7:52 PM
$ABCL ABCL wasted another day for long term investors 🤮🤮🤮🤮🤮
2 · Reply
ispy
ispy Mar. 25 at 5:07 PM
$ABCL has same issue as Kermit... it's not easy being green.
0 · Reply
ispy
ispy Mar. 25 at 4:50 PM
$ABCL it's this a bull flag forming?
0 · Reply
Ed_Ng
Ed_Ng Mar. 25 at 3:32 PM
$ABCL pump and dump as always
0 · Reply
DeMampCamp
DeMampCamp Mar. 25 at 2:11 PM
$ABCL What a monster recovery from yesterday's $3.27 print! 20MA is at $3.54, we're back above the 200MA now as well! Cheers, folks!
1 · Reply
Rastafari
Rastafari Mar. 25 at 2:09 PM
$ABCL why the bump this morning. Hope it doesn’t close a day with a one cent gain!
0 · Reply
manojaggarwal
manojaggarwal Mar. 24 at 11:26 PM
$ABCL in 5 years this can be at $100+
3 · Reply
8008track
8008track Mar. 24 at 6:52 PM
$ABCL bought more today
0 · Reply
tradersunion353
tradersunion353 Mar. 24 at 2:18 PM
$ABCL Hello sir $ABCL , what’s your plan for long-term investors here? Can we expect $8 by the end of 2026? It looks like you’re very comfortable in the $3 range and don’t want to step out of that comfort zone.
2 · Reply
Ed_Ng
Ed_Ng Mar. 24 at 1:53 PM
$ABCL soon $2
1 · Reply
tkstockpicker
tkstockpicker Mar. 24 at 1:18 PM
$ABCL bought some back
0 · Reply
DragonAlgo
DragonAlgo Mar. 24 at 5:07 AM
🐉 $ABCL PUT — DragonAlgo® Signal Contract: ABCL PUT Expiry: 2026-04-17 | Strike: $3.00 | Type: PUT Option Plan (premium): Entry: $0.17 Stop: $0.12 TP1: $0.22 TP2: $0.29 TP3: $0.41 Momentum tape remains active. 🔗 https://dragonalgo.com
0 · Reply
DeMampCamp
DeMampCamp Mar. 23 at 8:54 PM
$ABCL Today's ridiculous trading action is normal for us longs, unfortunately. Hang in there everyone, cheers!
0 · Reply
tradersunion353
tradersunion353 Mar. 23 at 1:07 PM
$ABCL There are plenty of positive posts about ABCL, but that optimism hasn’t translated into the stock price—recent performance has been quite weak. Long-term investors (2–3 years) should ideally start seeing some benefit soon. If you’re planning to hold for a decade aiming for 100–200% returns, you can disregard this perspective.
1 · Reply